Cardiovascular Event Risks May Be Affected by Timing of Meals

Share this content:
Cardiovascular Event Risks May Be Affected by Timing of Meals
Cardiovascular Event Risks May Be Affected by Timing of Meals

TUESDAY, Jan. 31, 2017 (HealthDay News) -- A new statement from the American Heart Association (AHA), published online Jan. 30 in Circulation, highlights what's known -- and what's not -- about meal timing and cardiovascular health.

The report is a response to the growing evidence that timing matters when it comes to cardiovascular disease risk, lead author Marie-Pierre St-Onge, Ph.D., an associate professor of nutritional medicine at Columbia University in New York City, told HealthDay. The various organs of the body have their own "clocks," St-Onge explained, and that may affect how we handle food at different times of the day and night.

A number of studies have found that breakfast eaters are generally healthier than breakfast skippers: They tend to weigh less, have better blood pressure and cholesterol numbers, and have lower risks of type 2 diabetes and cardiovascular disease, according to the AHA. Studies that track people in the real world have found that those who eat more often during the day have a lower risk of obesity and better cholesterol levels.

The statement lacks specific rules, such as "never eat after 8 p.m.," or "everyone should eat breakfast." It does, however, suggest that people spread out their calories over a "defined" period of the day -- as opposed to either eating a lot over a short period, or grazing from morning until night. Based on the evidence, the AHA says, it's probably a good idea to consume most of the day's calories earlier in the day.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »